⌘K

Login Start Free

Home/Filings/4/0001209191-22-057381

4//SEC Filing

Byrnes Michael 4

Accession 0001209191-22-057381

CIK 0001828522other

View on SEC.gov Company Profile

Filed

Nov 15, 7:00 PM ET

Accepted

Nov 16, 6:30 PM ET

Size

4.9 KB

Accession

0001209191-22-057381

Insider Transaction Report

Form 4

Period: 2022-11-15

eFFECTOR Therapeutics, Inc.EFTR

Chief Financial Officer

Transactions

Award
Common Stock
2022-11-15$0.47/sh+4,651$2,179→ 33,884 total

Footnotes (1)

[F1]These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

eFFECTOR Therapeutics, Inc.

CIK 0001828522

Entity typeother

Related Parties

1

filerCIK 0001619893

Filing Metadata

Form type: 4
Filed: Nov 15, 7:00 PM ET
Accepted: Nov 16, 6:30 PM ET
Size: 4.9 KB

View on SEC.gov